A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis
Clinical trial NCT02195349 · COMPLETED
Trial details
- NCT number
- NCT02195349
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-30
- Primary completion
- 2018-03-07
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.